IP Library › Granted Patent US 11,353,457
Granted Patent B2
US 11,353,457 · App. 16/916,273 · Granted Jun 7, 2022

Species specific antigen sequences for tick-borne relapsing fever (TBRF) and methods of use

Inventors: Jyotsna S. Shah (Santa Clara, CA); Song Liu (San Jose, CA)
Assignee: ID-Fish Technology, Inc.
G01N33/56911G01N33/581G01N33/582G01N33/60G01N33/6857G01N2333/20G01N2469/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,353,457
App. No.
16/916,273
Granted
Jun 7, 2022
Kind
B2
Abstract

Compositions and methods for the detection and identification of Tick-Borne Relapsing Fever Borrelia sp. antibodies.

Claims (12)

1. A composition comprising one or more amino acid sequences bound to a solid support, wherein the one or more bound amino acid sequences consist of amino acid sequences selected from the group consisting of SEQ ID NO: 9, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, and SEQ ID NO: 20.

2. The composition of claim 1 , wherein said amino acid sequences are bound to a solid support selected from the group consisting of nitrocellulose, nylon, polyvinylidene difluoride (PVDF), magnetic beads, metal, plastic, and agarose.

3. A method of detecting antibodies to one or more of B. hermsii, B. turicatae, B. miyamotoi, B. turcica , and B. coriaceae amino acid sequences in a sample from a subject suspected of having tick-borne relapsing fever (TBRF), said method comprising:

providing a biological sample obtained from a subject suspected of having TBRF;

mixing the biological sample with one or more of the bound amino acid sequences of claim 1 ; and

detecting a positive immunobinding reaction which indicates the presence of TBRF specific antibodies in the sample.

4. The method of claim 3 , wherein biological sample is considered positive for TBRF if at least two bound amino acid sequences are detected.

5. The method of claim 3 , wherein the bound amino acid sequences, complexed with antibodies to one or more of B. hermsii, B. turicatae, B. miyamotoi, B. turcica , and B. coriaceae , are detected using anti-human IgG or anti-human IgM antibody linked to a detectable moiety.

6. The method of claim 5 , wherein said detectable moiety is selected from the group consisting of chromophores, radioactive moieties and enzymes.

7. The method of claim 5 , wherein said detectable moiety comprises alkaline phosphatase.

8. The method of claim 5 , wherein said detectable moiety comprises biotin.

9. The method of claim 4 , wherein the at least two bound amino acid sequences detected are group-specific and are detected from the groups selected from: (1) 21-23 kDa; (2) 41 kDa; (3) 70-75 kDa; and (4) GlpQ; and wherein the at least two bound sequences are not specific for the same group.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2021
From: SHAH, JYOTSNA S.; LIU, SONG
To: ID-FISH TECHNOLOGY, INC.
Reel/Frame 057606/0272 →
Continuity (2)
Division 15916717 · Mar 9, 2018
Related Publication 20200348301A1 · Nov 5, 2020
Cited By (1)
US 12,638,446